Cargando…

Activation loop targeting strategy for design of receptor-interacting protein kinase 2 (RIPK2) inhibitors

Development of selective kinase inhibitors remains a challenge due to considerable amino acid sequence similarity among family members particularly in the ATP binding site. Targeting the activation loop might offer improved inhibitor selectivity since this region of kinases is less conserved. Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suebsuwong, Chalada, Pinkas, Daniel M., Ray, Soumya S., Bufton, Joshua C., Dai, Bing, Bullock, Alex N., Degterev, Alexei, Cuny, Gregory D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science Ltd 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819902/ https://www.ncbi.nlm.nih.gov/pubmed/29409752 http://dx.doi.org/10.1016/j.bmcl.2018.01.044

Ejemplares similares

Small molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signaling
por: Hrdinka, Matous, et al.
Publicado: (2018)

Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors
por: Canning, Peter, et al.
Publicado: (2015)

Targeting RIPK1,2,3 to combat inflammation
por: Bullock, Alex N., et al.
Publicado: (2015)

Targeting RIPK1 for the treatment of human diseases
por: Degterev, Alexei, et al.
Publicado: (2019)

Antioxidant and food additive BHA prevents TNF cytotoxicity by acting as a direct RIPK1 inhibitor
por: Delanghe, Tom, et al.
Publicado: (2021)

HIV-1 protease cleaves the serine-threonine kinases RIPK1 and RIPK2
por: Wagner, Roland N., et al.
Publicado: (2015)

Synthesis, in Vitro Evaluation and Cocrystal Structure of 4-Oxo-[1]benzopyrano[4,3-c]pyrazole Cryptosporidium parvum Inosine 5′-Monophosphate Dehydrogenase (CpIMPDH) Inhibitors
por: Sun, Zhuming, et al.
Publicado: (2014)

Constitutive Interferon Attenuates RIPK1/3-Mediated Cytokine Translation
por: Muendlein, Hayley I., et al.
Publicado: (2020)

ZBP1 promotes inflammatory responses downstream of TLR3/TLR4 via timely delivery of RIPK1 to TRIF
por: Muendlein, Hayley I., et al.
Publicado: (2022)

Advances in RIPK1 kinase inhibitors
por: Chen, Lu, et al.
Publicado: (2022)

ZBP1 promotes LPS-induced cell death and IL-1β release via RHIM-mediated interactions with RIPK1
por: Muendlein, Hayley I., et al.
Publicado: (2021)

Structural complexity in the KCTD family of Cullin3-dependent E3 ubiquitin ligases
por: Pinkas, Daniel M., et al.
Publicado: (2017)

Akt Regulates TNFα Synthesis Downstream of RIP1 Kinase Activation during Necroptosis
por: McNamara, Colleen R., et al.
Publicado: (2013)

RIPK1 activation mediates neuroinflammation and disease progression in multiple sclerosis
por: Zelic, Matija, et al.
Publicado: (2021)

Decreased RIPK1 expression in chondrocytes alleviates osteoarthritis via the TRIF/MyD88-RIPK1-TRAF2 negative feedback loop
por: Liang, Shuang, et al.
Publicado: (2019)

Erratum: Advances in RIPK1 kinase inhibitors
Publicado: (2023)

Design, synthesis and biological evaluation of 4-aminoquinoline derivatives as receptor-interacting protein kinase 2 (RIPK2) inhibitors
por: Fan, Tiantian, et al.
Publicado: (2022)

Discovery of a cooperative mode of inhibiting RIPK1 kinase
por: Meng, Huyan, et al.
Publicado: (2021)

Ubiquitination of RIPK1 suppresses programmed cell death by regulating RIPK1 kinase activation during embryogenesis
por: Zhang, Xixi, et al.
Publicado: (2019)

Inhibition of RIPK1 kinase does not affect diabetes development: β-Cells survive RIPK1 activation
por: Takiishi, Tatiana, et al.
Publicado: (2023)

Ubiquitin-Mediated Regulation of RIPK1 Kinase Activity Independent of IKK and MK2
por: Annibaldi, Alessandro, et al.
Publicado: (2018)

Genetic inhibition of RIPK3 ameliorates functional outcome in controlled cortical impact independent of necroptosis
por: Wu, Limin, et al.
Publicado: (2021)

Characterization and structure of the human lysine-2-oxoglutarate reductase domain, a novel therapeutic target for treatment of glutaric aciduria type 1
por: Leandro, João, et al.
Publicado: (2022)

Targeting RIPK1 kinase for modulating inflammation in human diseases
por: Li, Wanjin, et al.
Publicado: (2023)

The Role of RIPK1 and RIPK3 in Cardiovascular Disease
por: DeRoo, Elise, et al.
Publicado: (2020)

Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasis
por: Yan, Yiwu, et al.
Publicado: (2022)

Depletion of RIPK3 or MLKL blocks TNF-driven necroptosis and switches towards a delayed RIPK1 kinase-dependent apoptosis
por: Remijsen, Q, et al.
Publicado: (2014)

RIPK1 and RIPK3 inhibitors: potential weapons against inflammation to treat diabetic complications
por: Ke, Dan, et al.
Publicado: (2023)

Ripk1 and haematopoiesis: a case for LUBAC and Ripk3
por: Annibaldi, Alessandro, et al.
Publicado: (2018)

Tyrosine kinase inhibitors of Ripk2 attenuate bacterial cell wall-mediated lipolysis, inflammation and dysglycemia
por: Duggan, Brittany M., et al.
Publicado: (2017)

T1AM Attenuates the Hypoxia/Reoxygenation-Induced Necroptosis of H9C2 Cardiomyocytes via RIPK1/RIPK3 Pathway
por: Wei, Bo, et al.
Publicado: (2022)

Caspase-8, receptor-interacting protein kinase 1 (RIPK1), and RIPK3 regulate retinoic acid-induced cell differentiation and necroptosis
por: Someda, Masataka, et al.
Publicado: (2019)

SPATA2 regulates the activation of RIPK1 by modulating linear ubiquitination
por: Wei, Ran, et al.
Publicado: (2017)

RIPK2: a promising target for cancer treatment
por: You, Jieqiong, et al.
Publicado: (2023)

The amyloid structure of mouse RIPK3 (receptor interacting protein kinase 3) in cell necroptosis
por: Wu, Xia-lian, et al.
Publicado: (2021)

TNFR2 unlocks a RIPK1 kinase activity-dependent mode of proinflammatory TNFR1 signaling
por: Siegmund, Daniela, et al.
Publicado: (2018)

A pancancer analysis of the carcinogenic role of receptor-interacting serine/threonine protein kinase-2 (RIPK2) in human tumours
por: Zhang, Hanqun, et al.
Publicado: (2022)

Structure shows that the BIR2 domain of E3 ligase XIAP binds across the RIPK2 kinase dimer interface
por: Lethier, Mathilde, et al.
Publicado: (2023)

Influence of protein kinase RIPK4 expression on the apoptosis and proliferation of chondrocytes in osteoarthritis
por: Zou, Lixue, et al.
Publicado: (2018)

Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target
por: Mifflin, Lauren, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jarktvhlh2q679h75eqpg863o2